|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Current assets: | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Accounts receivable, net | ||||||||||||||||
| Unbilled contracts receivable, net | ||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||
| Note receivable | ||||||||||||||||
| Deferred consideration from divestiture | ||||||||||||||||
| Assets held for sale | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Note receivable, noncurrent | ||||||||||||||||
| Deferred consideration from divestiture, noncurrent | ||||||||||||||||
| Unbilled contracts receivable, noncurrent | ||||||||||||||||
| Property and equipment, net | ||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||
| Intangible assets, net | ||||||||||||||||
| Goodwill | ||||||||||||||||
| Deferred tax assets | ||||||||||||||||
| Other noncurrent assets | ||||||||||||||||
| Assets held for sale, noncurrent | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||
| Current liabilities: | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Accrued liabilities | ||||||||||||||||
| Deferred revenue | ||||||||||||||||
| Short-term debt | ||||||||||||||||
| Liabilities held for sale | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Long-term debt | ||||||||||||||||
| Deferred revenue, noncurrent | ||||||||||||||||
| Operating lease liabilities, noncurrent | ||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||
| Liabilities held for sale, noncurrent | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Stockholders' equity: | ||||||||||||||||
| Preferred stock: $0.001 par value; 6,000 shares authorized as of June 30, 2026 and December 31, 2025; no shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||
| Common stock: $0.001 par value; 140,000 shares authorized as of June 30, 2026 and December 31, 2025; 48,745 and 46,925 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Total Company stockholders' equity | ||||||||||||||||
| Noncontrolling interest | ||||||||||||||||
| Total stockholders' equity | ||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
